FDC Ltd (FDC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 248455, "name": "FDC", "stock_name": "FDC", "full_name": "FDC Ltd", "name_url": "stocks-analysis/fdc", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "380.50", "chg": 11.8, "chgp": "3.2%", "dir": 1, "prev_price": "368.70", "mcapval": "6,194.92 Cr", "mcap": "Small Cap", "scripcode": 531599, "symbol": "FDC", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE258B01022", "curr_date": "Feb 09", "curr_time": "", "bse_nse_vol": "64.7 k", "exc_status": "Active", "traded_date": "Feb 09, 2026", "traded_date_str": "2026 02 09", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fdc-248455-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "FDC Ltd Valuation Shifts Signal Deteriorating Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-valuation-shifts-signal-deteriorating-price-attractiveness-amid-sector-challenges-3827730", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_valuationdot_3827730.png", "date": "2026-02-09 08:00:28", "description": "FDC Ltd’s valuation metrics have recently shifted from fair to expensive territory, prompting a reassessment of its price attractiveness relative to historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector. Despite a strong market cap grade, the company’s deteriorating mojo score and downgraded rating to Strong Sell highlight growing investor caution amid subdued returns and stretched multiples." }, { "title": "FDC Ltd Declines 2.29% Amid Valuation Concerns and Weak Q3 Results", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-declines-229-amid-valuation-concerns-and-weak-q3-results-3827387", "imagepath": "", "date": "2026-02-08 11:02:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Valuation shifts to expensive amid mixed market returns</p>\n <p><strong>5 Feb:</strong> Q3 FY26 results reveal profit margin contraction</p>\n <p><strong>6 Feb:</strong> Stock hits 52-week low of Rs.357.45</p>\n <p><strong>6 Feb:</strong> Week closes at Rs.368.70 (-2.29%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.377.35</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.368.70</div><div class=\"stat-change neg..." }, { "title": "FDC Ltd Stock Falls to 52-Week Low of Rs.357.45 Amidst Weak Financial Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-stock-falls-to-52-week-low-of-rs35745-amidst-weak-financial-performance-3824311", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_priceRelatedfactors_3824311.png", "date": "2026-02-06 11:12:29", "description": "Shares of FDC Ltd, a player in the Pharmaceuticals & Biotechnology sector, declined sharply to hit a new 52-week low of Rs.357.45 on 6 February 2026, marking a significant milestone in the stock’s ongoing downward trajectory." }, { "title": "Are FDC Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-fdc-ltd-latest-results-good-or-bad-3822834", "imagepath": "", "date": "2026-02-05 19:18:40", "description": "FDC Ltd's latest financial results for Q3 FY26 reveal significant operational challenges. The company reported net sales of ₹464.71 crores, reflecting a marginal year-on-year increase of 0.13%, but a sequential decline of 1.76% compared to the previous quarter. This indicates a struggle to maintain revenue levels in a competitive environment. \n\nThe net profit for the quarter was ₹28.30 crores, which represents a year-on-year decrease of 23.60% and a slight sequential decline of 0.25%. This persistent drop in net profit raises concerns about the company's profitability and operational efficiency.\n\nA critical highlight from the results is the operating profit margin, which fell to 11.25% from 22.97% in the same quarter last year, marking a substantial erosion of 11.72 percentage points. This decline suggests that FDC is facing severe margin pressures, likely due to rising costs and competitive pricing strateg..." }, { "title": "FDC Ltd Q3 FY26: Profit Margins Crumble as Other Income Props Up Bottom Line", "link": "https://www.marketsmojo.com/news/result-analysis/fdc-ltd-q3-fy26-profit-margins-crumble-as-other-income-props-up-bottom-line-3822795", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDC_quaterlyResult_3822795.png", "date": "2026-02-05 17:45:43", "description": "FDC Ltd., the Mumbai-based pharmaceutical company specialising in formulations and active pharmaceutical ingredients, delivered a disappointing Q3 FY26 performance, with net profit declining 23.60% year-on-year to ₹28.30 crores despite relatively flat revenue growth. The stock has plunged 28.90% from its 52-week high of ₹528.30, currently trading at ₹375.60 with a market capitalisation of ₹6,202 crores, reflecting mounting investor concerns over deteriorating operational efficiency and margin compression." }, { "title": "FDC Ltd Valuation Shifts to Expensive Amidst Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-valuation-shifts-to-expensive-amidst-mixed-market-returns-3815248", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_valuationdot_3815248.png", "date": "2026-02-02 08:00:40", "description": "FDC Ltd’s valuation metrics have shifted notably, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving into the expensive territory compared to historical averages and peer benchmarks. This re-rating, coupled with a recent downgrade to a Strong Sell rating by MarketsMOJO, underscores growing concerns about the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector." }, { "title": "FDC Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-strong-sell-3814165", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FDCLtd_mojoScore_3814165.png", "date": "2026-02-01 10:10:22", "description": "FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "FDC Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-strong-sell-3798241", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/FDCLtd_mojoScore_3798241.png", "date": "2026-01-21 10:10:20", "description": "FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "FDC Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-ltd-is-rated-strong-sell-3788079", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/FDCLtd_mojoScore_3788079.png", "date": "2026-01-10 10:10:20", "description": "FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook." } ], "total": 214, "sid": "248455", "stock_news_url": "https://www.marketsmojo.com/news/fdc-248455" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "05-Feb-2026", "details": "Press Release for unaudited financial results for Quarter and Nine months ended December 31 2025.", "source": "BSE" }, { "caption": "Corporate Action-Board approves Dividend", "datetime": "05-Feb-2026", "details": "We hereby inform that the Board meeting held on February 05 2026 has approved an Interim Dividend of Rs. 5/- per Equity Share of face value of Rs. 1/- each for financial year 2025-26.", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting", "datetime": "05-Feb-2026", "details": "We hereby inform that the Board meeting held on February 05 2026 has inter alia approved the unaudited (standalone and consolidated ) financial results for Quarter and Nine Months ended 31st December 2025. Further the Board has approved an Interim Dividend of Rs. 5/- per Equity Share of face value Rs. 1/- each for financial year 2025-26.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "FDC Ltd has declared <strong>500%</strong> dividend, ex-date: 22 Nov 24", "dt": "2024-11-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Valuation shifts to expensive amid mixed market returns

5 Feb: Q3 FY26 results reveal profit margin contraction

6 Feb: Stock hits 52-week low of Rs.357.45

6 Feb: Week closes at Rs.368.70 (-2.29%)

Read full news article

FDC Ltd Stock Falls to 52-Week Low of Rs.357.45 Amidst Weak Financial Performance

2026-02-06 11:12:29

Shares of FDC Ltd, a player in the Pharmaceuticals & Biotechnology sector, declined sharply to hit a new 52-week low of Rs.357.45 on 6 February 2026, marking a significant milestone in the stock’s ongoing downward trajectory.

Read full news article

Are FDC Ltd latest results good or bad?

2026-02-05 19:18:40

FDC Ltd's latest financial results for Q3 FY26 reveal significant operational challenges. The company reported net sales of ₹464.71 crores, reflecting a marginal year-on-year increase of 0.13%, but a sequential decline of 1.76% compared to the previous quarter. This indicates a struggle to maintain revenue levels in a competitive environment. The net profit for the quarter was ₹28.30 crores, which represents a year-on-year decrease of 23.60% and a slight sequential decline of 0.25%. This persistent drop in net profit raises concerns about the company's profitability and operational efficiency. A critical highlight from the results is the operating profit margin, which fell to 11.25% from 22.97% in the same quarter last year, marking a substantial erosion of 11.72 percentage points. This decline suggests that FDC is facing severe margin pressures, likely due to rising costs and competitive pricing strateg...

Read full news article

FDC Ltd Q3 FY26: Profit Margins Crumble as Other Income Props Up Bottom Line

2026-02-05 17:45:43

FDC Ltd., the Mumbai-based pharmaceutical company specialising in formulations and active pharmaceutical ingredients, delivered a disappointing Q3 FY26 performance, with net profit declining 23.60% year-on-year to ₹28.30 crores despite relatively flat revenue growth. The stock has plunged 28.90% from its 52-week high of ₹528.30, currently trading at ₹375.60 with a market capitalisation of ₹6,202 crores, reflecting mounting investor concerns over deteriorating operational efficiency and margin compression.

Read full news article

FDC Ltd Valuation Shifts to Expensive Amidst Mixed Market Returns

2026-02-02 08:00:40

FDC Ltd’s valuation metrics have shifted notably, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving into the expensive territory compared to historical averages and peer benchmarks. This re-rating, coupled with a recent downgrade to a Strong Sell rating by MarketsMOJO, underscores growing concerns about the stock’s price attractiveness within the Pharmaceuticals & Biotechnology sector.

Read full news article

FDC Ltd is Rated Strong Sell

2026-02-01 10:10:22

FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 01 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

FDC Ltd is Rated Strong Sell

2026-01-21 10:10:20

FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

FDC Ltd is Rated Strong Sell

2026-01-10 10:10:20

FDC Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article